The same family of artificial intelligence that powers today's image generators is now being aimed at one of biology's ...
The AI tool AlphaFold has been improved so that it can now predict the shape of very large and complex protein structures. Researchers have also succeeded in integrating experimental data into the ...
Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is pairing ...
An AI breakthrough from an Alphabet-owned startup is speeding up the hunt for new drugs. The technology, called AlphaFold2, has been used by over 1 million researchers to study proteins. Several ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More A trio of scientists consisting of Demis Hassabis, co-founder and CEO of ...
AlphaFold arrived as a technical moonshot that suddenly made protein structures feel like software rather than secrets of nature, and five years on it has rewired how laboratories plan experiments, ...
AlphaFold 3 extends beyond protein structures to model DNA, RNA, and all molecular structures vital to life. This advancement promises transformative applications in medicine, agriculture, materials ...
A key Google DeepMind engineer is leaving for Anthropic. He's the latest Silicon Valley name to join the AI giant. John ...
Add Yahoo as a preferred source to see more of our stories on Google. In April 2025, Isomorphic Labs raised a $600 million in its first-ever external funding round, led by Thrive Capital. Alphabet’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results